Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Severstal presented its development strategy until 2028

6/4/24 CHMF

Revenue of Mosgorlombard for January-May increased by 4.7 times

6/4/24 MGKL

IVA Technologies IPO will take place at the top of the range

6/4/24 IVAT

Shareholders of Agregat approved dividends for 2023

6/4/24 AGRT

Shareholders of Europlan approved dividends for 2023

6/4/24 LEAS

Find the Job has opened a round of investment raising

6/3/24 OTCI

RusHydro to commission 2.4 GW of power capacity by 2028

6/3/24 HYDR

TMK cancels SPO due to unfavorable market conditions

6/3/24 TRMK

Board of Directors of Abrau-Durso recommended that dividends be paid for 2023

6/3/24 ABRD

Shareholders of Krasnoyarskenergosbyt approved dividends for 2023

6/3/24 KRSB